The fact that CCL2 is released by a compressed nerve [66,67]—and, constitutively, by our melanoma cell line—may explain why 12 h after starting the gabapentin administration in the therapeutic protocol, a significant decrease in tumor size was observed. This evidence concerns the gene CCL2 and neoplasm.